Free Trial
OTCMKTS:CHGCY

Chugai Pharmaceutical (CHGCY) Stock Price, News & Analysis

Chugai Pharmaceutical logo
$23.75 +0.61 (+2.63%)
As of 10:29 AM Eastern

About Chugai Pharmaceutical Stock (OTCMKTS:CHGCY)

Advanced

Key Stats

Today's Range
$23.59
$24.05
50-Day Range
$23.14
$29.27
52-Week Range
$19.50
$34.84
Volume
46,030 shs
Average Volume
228,119 shs
Market Capitalization
$78.16 billion
P/E Ratio
26.39
Dividend Yield
2.61%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Chugai Pharmaceutical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

CHGCY MarketRank™: 

Chugai Pharmaceutical scored higher than 68% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chugai Pharmaceutical has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Chugai Pharmaceutical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Chugai Pharmaceutical's stock forecast and price target.
  • Earnings Growth

    Earnings for Chugai Pharmaceutical are expected to grow by 30.61% in the coming year, from $0.98 to $1.28 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chugai Pharmaceutical is 25.71, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.77.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chugai Pharmaceutical is 25.71, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.12.

  • Price to Book Value per Share Ratio

    Chugai Pharmaceutical has a P/B Ratio of 5.62. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chugai Pharmaceutical's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Chugai Pharmaceutical has been sold short.
  • Short Interest Ratio / Days to Cover

    Chugai Pharmaceutical has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chugai Pharmaceutical has recently decreased by 97.22%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Chugai Pharmaceutical pays a meaningful dividend of 2.61%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chugai Pharmaceutical does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Chugai Pharmaceutical is 68.89%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Chugai Pharmaceutical will have a dividend payout ratio of 48.44% next year. This indicates that Chugai Pharmaceutical will be able to sustain or increase its dividend.

  • Read more about Chugai Pharmaceutical's dividend.
  • News Sentiment

    Chugai Pharmaceutical has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.
Receive CHGCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chugai Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHGCY Stock News Headlines

SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. But at a $1.75 trillion valuation and 266 times earnings, early institutional holders may be looking for someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure behind Colossus - still trading at a fraction of its potential value. No IPO allocation required.tc pixel
See More Headlines

CHGCY Stock Analysis - Frequently Asked Questions

Chugai Pharmaceutical's stock was trading at $26.27 at the start of the year. Since then, CHGCY shares have decreased by 11.9% and is now trading at $23.14.

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) posted its quarterly earnings results on Friday, April, 24th. The company reported $0.22 earnings per share (EPS) for the quarter. The company earned $2.05 billion during the quarter. Chugai Pharmaceutical had a trailing twelve-month return on equity of 22.90% and a net margin of 34.98%.

Shares of CHGCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/24/2026
Today
6/04/2026
Next Earnings (Estimated)
7/23/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:CHGCY
CIK
1453934
Fax
N/A
Employees
7,778
Year Founded
1925

Profitability

EPS (Trailing Twelve Months)
$0.90
Trailing P/E Ratio
26.54
Forward P/E Ratio
24.38
P/E Growth
N/A
Net Income
$2.91 billion
Net Margins
34.98%
Pretax Margin
47.52%
Return on Equity
22.90%
Return on Assets
19.45%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.70
Quick Ratio
3.82

Sales & Book Value

Annual Sales
$8.41 billion
Price / Sales
9.35
Cash Flow
$0.95 per share
Price / Cash Flow
25.10
Book Value
$4.12 per share
Price / Book
5.80

Miscellaneous

Outstanding Shares
3,291,430,000
Free Float
N/A
Market Cap
$78.63 billion
Optionable
Not Optionable
Beta
0.58

Social Links

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:CHGCY) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners